Drug-eluting stents: TCT (Transcatheter Cardiovascular Therapeutics) round-up
This article was originally published in Clinica
Executive Summary
This year's Transcatheter Cardiovascular Therapeutics (TCT) symposium in Washington, DC, established two strong contenders for the potentially explosive drug-eluting stent market - Johnson & Johnson's Cordis division and Boston Scientific.